Join the club for FREE to access the whole archive and other member benefits.

John Ramunas

CEO and co-founder of Rejuvenation Technologies Inc

Invented the first safe telomere extension drug, TERT mRNA, patented by Stanford. Invented the simplest pump, patented by Stanford. Co-founded Rejuvenation Technologies to make TERT mRNA-based telomere extension available as broadly and quickly as possible. Experienced founder with a demonstrated history of success, experienced in programming, molecular biology, stem cell biology, animal models, management, mentoring, and drug development. 3 patents, 14 publications, in PNAS, Nature Molecular Therapy, Sensors and Actuators, others. 

Visit website: https://rejuvenationtech.com/Team/

 johnramunas

See also: Company Rejuvenation Technologies - Biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres

Details last updated 04-Sep-2020

John Ramunas News

Rejuvenation Technologies raises $10.6M to develop anti-ageing therapies

Rejuvenation Technologies raises $10.6M to develop anti-ageing therapies

Longevity Technology - 07-Sep-2023

A single dose of mRNA therapy could rewind ageing and extend lifespan

Telomere extension turns back aging clock in cultured human cells

Telomere extension turns back aging clock in cultured human cells

Stanford University - 22-Jan-2015

Researchers delivered a modified RNA that encodes a telomere-extending protein to cultured human ...